FDA Adverse Event Injury Summary report: N

IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER

MDR report key: 6903287 · Received September 29, 2017

Report

Report Number
9612164-2017-01348
Event Type
Injury
Date Received
September 29, 2017
Date of Event
December 23, 2016
Report Date
May 15, 2017
Manufacturer
MEDTRONIC IRELAND
Product Code
ONU
PMA / PMN Number
P140010
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DATE OF PUBLICATION TITLE OF ARTICLE: DIRECTIONAL ATHERECTOMY WITH ANTIRESTENOTIC THERAPY VS DRUG-COATED BALLOON ANGIOPLASTY ALONE FOR ISOLATED POPLITEAL ARTERY LESIONS JOURNAL OF ENDOVASCULAR THERAPY 2017, VOL. 24(2) 181-188 DOI: 10.1177/1526602816683933 WWW.JEVT.ORG. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

A STUDY WAS CONDUCTED TO REPORT A SINGLE-CENTER STUDY COMPARING DRUG-COATED BALLOON (DCB) ANGIOPLASTY VS DIRECTIONAL ATHERECTOMY WITH ANTIRESTENOTIC THERAPY (DAART) FOR ISOLATED LESIONS OF THE POPLITEAL ARTERY. SEVENTY TWO SYMPTOMATIC PAD PATIENTS WITH AN AVERAGE AGE OF 72 YEARS, WITH A HISTORY OF HYPERTENSION, DIABETES MELLITUS, DYSLIPIDEMIA, CORONARY HEART DISEASE, CHRONIC KIDNEY DISEASE AND CEREBROVASCULAR DISEASE. THE PATIENTS WERE TREATED AT A SINGLE CENTER BETWEEN OCTOBER 2009 AND DECEMBER 2015 FOR ISOLATED POPLITEAL LESIONS. IN.PACT ADMIRAL, IN.PACT PACIFIC, SPIDER, TURBOHAWK, SILVERHAWK, HAWKONE ATHERECTOMY DEVICES WERE USED FOR THE PROCEDURES. THE DCB PATIENTS PRESENTED WITH DISTAL EMBOLIZATION, PERFORATED VESSEL WALL, FALSE ANEURYSM, HEMATOMA AND TARGET LESION REVASCULARIZATION (TLR).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
685416 IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER ONU MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention